Refine Search
(5)
(15)
(53)
(183)

Oncology

GlobalData provides unique and market-leading data and insights into the oncology market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Small Cell Lung Cancer: Diverse First-in-Class Pipeline Shows Promise of Targeted Therapies to Treat Aggressive Disease

  • $6,995
  • September 2019
Add to Basket Quick View Add to Saved List

Initially considered a curable disease due to substantial sensitivity to chemotherapy, small cell lung cancer (SCLC) remains a fatal disease with a poor outcome, with the majority of patients surviving one year or less after diagnosis. Unlike n...

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028

  • $10,995
  • September 2019
Add to Basket Quick View Add to Saved List

Ovarian cancer is a rare gynecological disease that spans a broad range of genetic and histological subtypes, for which platinum-based chemotherapy has been the standard of care (SOC) for decades. Ovarian cancer can be broken down into many dif...

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

  • $10,995
  • August 2019
Add to Basket Quick View Add to Saved List

The prostate cancer market in the 8 major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China) is expected to experience a moderate growth between 2018 and 2018. The main drivers of growth will be an aging population, continue...

Prostate Cancer: Epidemiology Forecast to 2028

  • $3,995
  • August 2019
Add to Basket Quick View Add to Saved List

Prostate cancer is a malignancy in the prostate gland, which is located below the bladder and in front of the rectum in males. Worldwide, about 1.2 million men were diagnosed with prostate cancer in 2018 (International Agency for Research on Ca...

Ovarian Cancer: Epidemiology Forecast to 2028

  • $3,995
  • July 2019
Add to Basket Quick View Add to Saved List

Ovarian cancer is the most lethal gynecologic cancer and overall a leading cause of cancer incidence and mortality worldwide. The disease is defined as uncontrolled cell growth in the ovaries, although research has shown that the disease may ac...

B-Cell Non-Hodgkin’s Lymphoma: Epidemiology Forecast to 2027

  • $3,995
  • June 2019
Add to Basket Quick View Add to Saved List

Non-Hodgkin’s lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the patient’s immune system is affected by the uncontrollable growth of malignant white blood cells, resulting in the body’s inability to fi...

B-Cell Non-Hodgkin’s Lymphoma (NHL): Opportunity Analysis and Forecasts to 2027

  • $10,995
  • June 2019
Add to Basket Quick View Add to Saved List

Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous group of proliferative malignancies that arise in the B cells, T cells, or natural killer (NK) cells within the lymphoid tissue, such as the lymph nodes, bone marrow, thymus, and spleen. B-...

Duodenal Cancer Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Duodenal Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Duodenal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Duode...

Endometrial Cancer Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Endometrial Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on...

Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2019" provides an overview of Diffuse Large B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to ...

Colon Cancer Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Colon Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Colon Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Colon Cance...

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2019" provides an overview of Cutaneous B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clin...

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2019" provides an overview of Cutaneous T-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clin...

Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides top line data re...

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical tria...

Join our mailing list
Find out first about the latest reports and offers.